Phase I/II study of GTI-2040 plus docetaxel as 2nd-line treatment in non-small cell lung cancer (NSCLC) and other solid tumors. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Leighl, NB
  • Laurie, SA
  • Knox, JJ
  • Ellis, PM
  • Shepherd, FA
  • Burkes, RL
  • Vincent, M
  • Pond, Gregory
  • Zwiebel, JA
  • Moore, MJ

publication date

  • June 1, 2005